CN103930210B - 微流体系统 - Google Patents
微流体系统 Download PDFInfo
- Publication number
- CN103930210B CN103930210B CN201280056545.3A CN201280056545A CN103930210B CN 103930210 B CN103930210 B CN 103930210B CN 201280056545 A CN201280056545 A CN 201280056545A CN 103930210 B CN103930210 B CN 103930210B
- Authority
- CN
- China
- Prior art keywords
- magnetic
- drop
- microchannel
- magnetic particle
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000005291 magnetic effect Effects 0.000 claims abstract description 240
- 239000006249 magnetic particle Substances 0.000 claims abstract description 125
- 239000012530 fluid Substances 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims description 69
- 239000002245 particle Substances 0.000 claims description 48
- 230000002776 aggregation Effects 0.000 claims description 28
- 238000004220 aggregation Methods 0.000 claims description 25
- 238000000605 extraction Methods 0.000 claims description 16
- 230000004913 activation Effects 0.000 claims description 11
- 230000005389 magnetism Effects 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 7
- 230000009849 deactivation Effects 0.000 claims description 3
- 230000005294 ferromagnetic effect Effects 0.000 claims description 3
- 230000009471 action Effects 0.000 claims description 2
- 239000011049 pearl Substances 0.000 description 44
- 238000004458 analytical method Methods 0.000 description 21
- 238000003018 immunoassay Methods 0.000 description 21
- 239000000523 sample Substances 0.000 description 21
- 238000001514 detection method Methods 0.000 description 20
- 239000000126 substance Substances 0.000 description 20
- 239000011324 bead Substances 0.000 description 18
- 239000007788 liquid Substances 0.000 description 16
- 238000002965 ELISA Methods 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 239000003446 ligand Substances 0.000 description 10
- 238000002156 mixing Methods 0.000 description 9
- 239000002105 nanoparticle Substances 0.000 description 9
- 206010010510 Congenital hypothyroidism Diseases 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 239000012491 analyte Substances 0.000 description 7
- 230000005284 excitation Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000004907 flux Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 239000004809 Teflon Substances 0.000 description 5
- 229920006362 Teflon® Polymers 0.000 description 5
- 230000004520 agglutination Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000000090 biomarker Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000005298 paramagnetic effect Effects 0.000 description 5
- 238000013139 quantization Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000004166 bioassay Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 230000005415 magnetization Effects 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 239000003656 tris buffered saline Substances 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 238000005054 agglomeration Methods 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 210000000080 chela (arthropods) Anatomy 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 239000000696 magnetic material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002096 quantum dot Substances 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 2
- 101710153593 Albumin A Proteins 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 229910001017 Alperm Inorganic materials 0.000 description 2
- 108091023037 Aptamer Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000003851 biochemical process Effects 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000005347 demagnetization Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229910000595 mu-metal Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 230000001646 thyrotropic effect Effects 0.000 description 2
- BCHIXGBGRHLSBE-UHFFFAOYSA-N (4-methyl-2-oxochromen-7-yl) dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C=CC2=C1OC(=O)C=C2C BCHIXGBGRHLSBE-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- KLLLJCACIRKBDT-UHFFFAOYSA-N 2-phenyl-1H-indole Chemical compound N1C2=CC=CC=C2C=C1C1=CC=CC=C1 KLLLJCACIRKBDT-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241001365789 Oenanthe crocata Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108010089430 Phosphoproteins Proteins 0.000 description 1
- 102000007982 Phosphoproteins Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000007818 agglutination assay Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 230000005290 antiferromagnetic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 238000011953 bioanalysis Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009582 blood typing Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 230000005293 ferrimagnetic effect Effects 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000000504 luminescence detection Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 239000000107 tumor biomarker Substances 0.000 description 1
- -1 vesica Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
- B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0673—Handling of plugs of fluid surrounded by immiscible fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0654—Lenses; Optical fibres
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/043—Moving fluids with specific forces or mechanical means specific forces magnetic forces
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/44—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of magnetic liquids, e.g. ferrofluids
- H01F1/447—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of magnetic liquids, e.g. ferrofluids characterised by magnetoviscosity, e.g. magnetorheological, magnetothixotropic, magnetodilatant liquids
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F21/00—Variable inductances or transformers of the signal type
- H01F21/02—Variable inductances or transformers of the signal type continuously variable, e.g. variometers
- H01F21/06—Variable inductances or transformers of the signal type continuously variable, e.g. variometers by movement of core or part of core relative to the windings as a whole
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Clinical Laboratory Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
Description
Claims (15)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161536132P | 2011-09-19 | 2011-09-19 | |
US61/536,132 | 2011-09-19 | ||
PCT/IB2012/053766 WO2013041983A1 (en) | 2011-09-19 | 2012-07-24 | Microfluidic system |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103930210A CN103930210A (zh) | 2014-07-16 |
CN103930210B true CN103930210B (zh) | 2018-06-12 |
Family
ID=46940557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280056545.3A Active CN103930210B (zh) | 2011-09-19 | 2012-07-24 | 微流体系统 |
Country Status (4)
Country | Link |
---|---|
US (1) | US10130949B2 (zh) |
EP (1) | EP2758173B1 (zh) |
CN (1) | CN103930210B (zh) |
WO (1) | WO2013041983A1 (zh) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201119032D0 (en) | 2011-11-03 | 2011-12-14 | Isis Innovation | Multisomes: encapsulated droplet networks |
GB201219196D0 (en) * | 2012-10-25 | 2012-12-12 | Isis Innovation | Droplet assembly method |
GB201219201D0 (en) | 2012-10-25 | 2012-12-12 | Isis Innovation | Hydrogel network |
EP2928610A2 (en) | 2012-12-07 | 2015-10-14 | Isis Innovation Limited | Droplet assembly by 3d printing |
WO2014207577A2 (en) * | 2013-06-18 | 2014-12-31 | Ell Biosystems Ltd. | Biomolecule isolation and thermal processing |
US9583257B2 (en) | 2014-07-18 | 2017-02-28 | Nokia Technologies Oy | Microfluidics controlled tunable coil |
FR3027396B1 (fr) * | 2014-10-15 | 2016-11-25 | Espci Innov | Procede d'analyse du contenu de gouttes et appareil associe |
NZ740994A (en) | 2015-10-02 | 2023-07-28 | Univ Leland Stanford Junior | Sorting biological and non-biological moieties using magnetic levitation |
CN105214742B (zh) * | 2015-10-10 | 2017-10-31 | 中国科学院深圳先进技术研究院 | 基于人工结构声场的微流体系统及操控微粒的方法 |
CN107085101A (zh) * | 2016-02-15 | 2017-08-22 | 葛宇杰 | 强疏水pdms作为基片材质的亚型猪流感检测用芯片装置 |
FR3050212B1 (fr) * | 2016-04-15 | 2020-09-25 | Chu Montpellier | Procede de detection et/ou de caracterisation de cellules tumorales et appareil associe |
JP6729026B2 (ja) * | 2016-06-15 | 2020-07-22 | ウシオ電機株式会社 | マイクロ流路チップおよび検体濃度測定装置 |
JP7097895B2 (ja) * | 2017-01-18 | 2022-07-08 | アボット・ラボラトリーズ | 試料分析のための方法およびデバイス |
EP4218738A1 (en) | 2017-02-24 | 2023-08-02 | The Regents of The University of California | Particle-drop structures and methods for making and using the same |
US10330511B2 (en) | 2017-06-22 | 2019-06-25 | Saudi Arabian Oil Company | Alternating magnetic field flow meters |
US10557730B2 (en) | 2017-06-22 | 2020-02-11 | Saudi Arabian Oil Company | Alternating magnetic field flow meters with embedded quality assurance and control |
EP3524356A1 (en) * | 2018-02-11 | 2019-08-14 | Universität Zürich | Devices for applying forces to ferromagnetic probes at both cellular and tissue levels |
CN117138854A (zh) * | 2018-07-20 | 2023-12-01 | Dh科技发展私人贸易有限公司 | 用于处理流体的电磁线圈组件结构及其制造方法 |
DE112019004459T5 (de) * | 2018-09-05 | 2021-07-15 | Adana Bilim Ve Teknoloji Universitesi | Anreicherung von proben mittels magnetischer partikel in mikrokanälen |
EP3629020B1 (en) * | 2018-09-25 | 2021-10-27 | bioMérieux | Microfluidic droplet-based assay process and apparatus |
US11162143B2 (en) | 2018-10-21 | 2021-11-02 | The University Of Kansas | Methods for generating therapeutic delivery platforms |
GB2582619A (en) * | 2019-03-28 | 2020-09-30 | Sumitomo Chemical Co | Enzyme linked assay methods and apparatuses |
CN111369877B (zh) * | 2020-03-02 | 2021-08-24 | 肇庆学院 | 一种无容器超微量化学反应观察装置 |
US11341830B2 (en) | 2020-08-06 | 2022-05-24 | Saudi Arabian Oil Company | Infrastructure construction digital integrated twin (ICDIT) |
CN112345474B (zh) * | 2020-11-11 | 2022-06-17 | 昆明理工大学 | 一种快速检测食品中特丁基对苯二酚的方法 |
US11687053B2 (en) | 2021-03-08 | 2023-06-27 | Saudi Arabian Oil Company | Intelligent safety motor control center (ISMCC) |
WO2023283752A1 (zh) * | 2021-07-12 | 2023-01-19 | 中国科学院深圳先进技术研究院 | 一种旋转控制模块、方法与系统 |
US12024985B2 (en) | 2022-03-24 | 2024-07-02 | Saudi Arabian Oil Company | Selective inflow control device, system, and method |
WO2024058781A1 (en) * | 2022-09-15 | 2024-03-21 | Hewlett-Packard Development Company, L.P. | Devices for dispensing an immunoreactive magnetic particle and immunoassay reporter in a fluid droplet |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1471828A1 (en) | 2002-01-18 | 2004-11-03 | California Institute Of Technology | Method and apparatus for nanomagnetic manipulation and sensing |
EP3616781A1 (en) | 2003-04-10 | 2020-03-04 | President and Fellows of Harvard College | Formation and control of fluidic species |
WO2010042637A2 (en) | 2008-10-07 | 2010-04-15 | Advanced Liquid Logic, Inc. | Bead incubation and washing on a droplet actuator |
EP3031918B1 (en) * | 2006-05-11 | 2018-03-14 | Raindance Technologies Inc. | Microfluidic devices |
EP1974821A1 (en) | 2007-03-26 | 2008-10-01 | F.Hoffmann-La Roche Ag | Method and apparatus for transporting magnetic or magnetisable microbeads |
ATE554859T1 (de) * | 2007-05-24 | 2012-05-15 | Univ California | Integrierte fluidische vorrichtungen mit magnetischer sortierung |
EP2229441B1 (en) * | 2007-12-12 | 2014-10-01 | The Board of Trustees of The Leland Stanford Junior University | Method and apparatus for magnetic separation of cells |
US7927561B2 (en) | 2008-01-10 | 2011-04-19 | Becton, Dickinson And Company | Rapid particle detection assay |
US9011777B2 (en) * | 2008-03-21 | 2015-04-21 | Lawrence Livermore National Security, Llc | Monodisperse microdroplet generation and stopping without coalescence |
EP2672259A1 (en) * | 2008-05-13 | 2013-12-11 | Advanced Liquid Logic, Inc. | Droplet actuator devices, systems and methods |
WO2010077859A2 (en) * | 2008-12-15 | 2010-07-08 | Advanced Liquid Logic, Inc. | Nucleic acid amplification and sequencing on a droplet actuator |
EP2599548B1 (de) | 2009-05-13 | 2018-07-04 | ibidi GmbH | Probenträger zum Positionieren einer organischen, biologischen und/oder medizinischen Probe |
US8846414B2 (en) * | 2009-09-29 | 2014-09-30 | Advanced Liquid Logic, Inc. | Detection of cardiac markers on a droplet actuator |
-
2012
- 2012-07-24 CN CN201280056545.3A patent/CN103930210B/zh active Active
- 2012-07-24 EP EP12766477.9A patent/EP2758173B1/en active Active
- 2012-07-24 WO PCT/IB2012/053766 patent/WO2013041983A1/en active Application Filing
- 2012-07-24 US US14/345,910 patent/US10130949B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN103930210A (zh) | 2014-07-16 |
EP2758173A1 (en) | 2014-07-30 |
US20140342373A1 (en) | 2014-11-20 |
EP2758173B1 (en) | 2019-07-24 |
US10130949B2 (en) | 2018-11-20 |
WO2013041983A1 (en) | 2013-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103930210B (zh) | 微流体系统 | |
Gijs et al. | Microfluidic applications of magnetic particles for biological analysis and catalysis | |
Verpoorte | Focusbeads and chips: New recipes for analysis | |
EP2579988B1 (en) | Non-linear magnetophoretic separation system and method | |
Teste et al. | A low cost and high throughput magnetic bead-based immuno-agglutination assay in confined droplets | |
EP2018537B1 (en) | Rapid magnetic biosensor | |
Serra et al. | The power of solid supports in multiphase and droplet-based microfluidics: towards clinical applications | |
US9863857B2 (en) | Device and method for particle complex handling | |
US20170363578A1 (en) | Method and device for biomolecule preparation and detection using magnetic array | |
US7820454B2 (en) | Programmable electromagnetic array for molecule transport | |
US8409877B2 (en) | Enzymatic signal generation and detection of binding complexes in stationary fluidic chip | |
Khizar et al. | Magnetic nanoparticles in microfluidic and sensing: From transport to detection | |
US20090053799A1 (en) | Trapping magnetic sorting system for target species | |
US20110127222A1 (en) | Trapping magnetic cell sorting system | |
JP2020514709A (ja) | 磁気式多ビーズアッセイのための方法および装置 | |
CN103562729A (zh) | 分子诊断平台 | |
JP2009544033A (ja) | センサ表面に対する磁性物体又は磁化可能物体の引き付け及び引き離し | |
Sharma et al. | Magnetic nanoparticles in microfluidics-based diagnostics: an appraisal | |
Huang et al. | AMPFLUID: Aggregation magnified post-assay fluorescence for ultrasensitive immunodetection on digital microfluidics | |
US20230109130A1 (en) | Methods and systems related to highly sensitive assays and delivering capture objects | |
Wang | Microfluidic Platforms for Digitalized Biological Sample Processing | |
WO2024129901A1 (en) | Kinetic immunoassay and enrichment systems and methods | |
van Reenen | Dynamic magnetic particle actuation for integrated lab-on-chip biosensing | |
van Reenen et al. | Magnetic Particle Actuation in Stationary Microfluidics for Integrated Lab-on-Chip Biosensors | |
Gottheil | Magnetic bead actuated microfluidic immunoassay platform for sensitive detection of biomarkers and pathogens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170814 Address after: French address Applicant after: National Center for scientific research Applicant after: Universite Pierre et Marie Curie, Paris Vi Applicant after: French state (represented by Minister of defence) Address before: France Applicant before: National Center for scientific research |
|
TA01 | Transfer of patent application right | ||
CB02 | Change of applicant information |
Address after: France Applicant after: National Center for scientific research Applicant after: Universite Pierre et Marie Curie, Paris Vi French state (represented by Minister of defence) Address before: French address Applicant before: National Center for scientific research Applicant before: Universite Pierre et Marie Curie, Paris Vi French state (represented by Minister of defence) |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190924 Address after: Fa Guo Bali Co-patentee after: Sorbonne University French state (represented by Minister of defence) Patentee after: National Scientific Research Center Address before: Fa Guo Bali Co-patentee before: Pierre and Marie Curie - Sixth University of Paris Patentee before: National Scientific Research Center Co-patentee before: French state (represented by Minister of defence) |
|
TR01 | Transfer of patent right |